Latest Articles
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Yahoo Finance
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Yahoo Finance
Published: Feb. 27, 2026, 4:47 p.m.
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data - TipRanks
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data TipRanks
Published: Feb. 27, 2026, 3:24 p.m.
Get the iRobot Roomba 104 for $70 less at Amazon - Mashable
Get the iRobot Roomba 104 for $70 less at Amazon Mashable
Published: Feb. 27, 2026, 3 p.m.
13 Years After Diagnosis, I Still Feel Unprotected As An Endometriosis Sufferer - HuffPost UK
13 Years After Diagnosis, I Still Feel Unprotected As An Endometriosis Sufferer HuffPost UK
Published: Feb. 27, 2026, 2:48 p.m.
Acrivon Therapeutics hosts webcast on ACR-368 trial at ESGO Congress - Investing.com
Acrivon Therapeutics hosts webcast on ACR-368 trial at ESGO Congress Investing.com
Published: Feb. 27, 2026, 2:18 p.m.
Acrivon (NASDAQ: ACRV) shows ACR-368 activity in endometrial cancer - Stock Titan
Acrivon (NASDAQ: ACRV) shows ACR-368 activity in endometrial cancer Stock Titan
Published: Feb. 27, 2026, 2 p.m.
Sanju Pal's endometriosis case: How painful periods impact workplace performances, IVF specialist weighs... - Moneycontrol.com
Sanju Pal's endometriosis case: How painful periods impact workplace performances, IVF specialist weighs... Moneycontrol.com
Published: Feb. 27, 2026, 1:35 p.m.
Prescribed without explanation: A Kashmiri woman’s fertility journey - Free Press Kashmir
Prescribed without explanation: A Kashmiri woman’s fertility journey Free Press Kashmir
Published: Feb. 27, 2026, 12:25 p.m.
Model Elsie Hewitt shares why she's not breastfeeding - Jacaranda FM
Model Elsie Hewitt shares why she's not breastfeeding Jacaranda FM
Published: Feb. 27, 2026, 8:05 a.m.
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus
Published: Feb. 27, 2026, 7:22 a.m.
Link copied to clipboard!